BIOCRYST PHARMACEUTICALS INC Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Biocryst Pharmaceuticals Inc Return On Assets for the quarter ending September 30, 2024 was -25.4 %, a 43.2% increase year-over-year.
  • Biocryst Pharmaceuticals Inc annual Return On Assets for 2023 was -43.6 %, a 5.37% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Return On Assets for 2022 was -46 %, a 11.5% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Return On Assets for 2021 was -52 %, a 38.7% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -43.6 +2.47 +5.37% Jan 1, 2023 Dec 31, 2023
2022 -46 +5.97 +11.5% Jan 1, 2022 Dec 31, 2022
2021 -52 +32.8 +38.7% Jan 1, 2021 Dec 31, 2021
2020 -84.8 -1.76 -2.12% Jan 1, 2020 Dec 31, 2020
2019 -83.1 -16.4 -24.5% Jan 1, 2019 Dec 31, 2019
2018 -66.7 -23.8 -55.3% Jan 1, 2018 Dec 31, 2018
2017 -42.9 +17.3 +28.7% Jan 1, 2017 Dec 31, 2017
2016 -60.2 -28.4 -89.4% Jan 1, 2016 Dec 31, 2016
2015 -31.8 +7.56 +19.2% Jan 1, 2015 Dec 31, 2015
2014 -39.4 +24.4 +38.3% Jan 1, 2014 Dec 31, 2014
2013 -63.8 -7.5 -13.3% Jan 1, 2013 Dec 31, 2013
2012 -56.3 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.